LIFEMD, INC. Deferred Revenue
LIFEMD, INC. (LFMD) had Deferred Revenue of $10.79 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-08-05
- 2026-06-30: Deferred Revenue, Current $10.79M.
- 2026-03-31: Deferred Revenue, Current $12.02M.
- 2025-12-31: Deferred Revenue, Current $10.81M.
- 2025-09-30: Deferred Revenue, Current $14.36M.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2026-06-30 | $10.79M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $12.02M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $10.81M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $14.36M 10-Q · filed 2025-11-17 | |
| 2025-06-30 | $14.51M 10-Q · filed 2026-08-05 | $11.79M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $17.30M 10-Q · filed 2026-08-05 | $14.63M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $17.10M 10-Q · filed 2026-08-05 | $14.48M 10-K · filed 2025-03-11 |
| 2024-09-30 | $20.59M 10-Q · filed 2025-11-17 | $16.39M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $18.44M 10-Q · filed 2025-11-17 | $15.16M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $13.20M 10-Q · filed 2025-08-05 | |
| 2023-12-31 | $7.27M 10-K · filed 2026-03-10 | $8.83M 10-K · filed 2024-03-11 |
| 2023-09-30 | $6.24M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $5.67M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $5.90M 10-Q · filed 2024-08-07 | |
| 2022-12-31 | $5.55M 10-K · filed 2025-03-11 | |
| 2022-09-30 | $2.35M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $1.99M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $1.50M 10-K · filed 2024-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |